Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Return on Assets (2018 - 2020)

Monopar Therapeutics (MNPR) has disclosed Return on Assets for 3 consecutive years, with 0.35% as the latest value for Q3 2020.

  • Quarterly Return on Assets rose 40.0% to 0.35% in Q3 2020 from the year-ago period, while the trailing twelve-month figure was 0.35% through Sep 2020, up 40.0% year-over-year, with the annual reading at 0.42% for FY2019, 4.0% down from the prior year.
  • Return on Assets hit 0.35% in Q3 2020 for Monopar Therapeutics, up from 0.36% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.31% in Q1 2020 to a low of 1.96% in Q2 2018.
  • Historically, Return on Assets has averaged 0.72% across 3 years, with a median of 0.47% in 2019.
  • Biggest YoY gain for Return on Assets was 130bps in 2019; the steepest drop was -39bps in 2019.
  • Year by year, Return on Assets stood at 0.42% in 2018, then dropped by -13bps to 0.47% in 2019, then grew by 25bps to 0.35% in 2020.
  • Business Quant data shows Return on Assets for MNPR at 0.35% in Q3 2020, 0.36% in Q2 2020, and 0.31% in Q1 2020.